GoldenGolden
Tate & Lyle Ventures

Tate & Lyle Ventures

A venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors

All edits

Edits on 21 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 21 Feb, 2020
Edits made to:
Article (+14/-14 characters)
Article

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United KingdomUnited Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 21 Feb, 2020
Edits made to:
Article (+15/-15 characters)
Article

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing HealthChanging Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 21 Feb, 2020
Edits made to:
Article (+17/-17 characters)
Article

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve BiosystemsEvolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 21 Feb, 2020
Edits made to:
Article (+7/-7 characters)
Article

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, EnglandEngland, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Edits on 20 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb, 2020
Edits made to:
Article (+20/-20 characters)
Article

Tate & Lyle Ventures is a venture capital firmventure capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb, 2020
Edits made to:
Article (+6/-6 characters)
Article

Tate & Lyle Ventures is a venture capital firm in LondonLondon that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 20 Feb, 2020
Edits made to:
Article (+7/-7 characters)
Article

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, AllylixAllylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 20 Feb, 2020
Edits made to:
Description (+123/-115 characters)
Article (+667 characters)
Topic thumbnail

Tate & Lyle Ventures

Tate & Lyle Ventures is a venture capital fund investing in companies in the fields of food science and technology.

A venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors

Article

Tate & Lyle Ventures is a venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors. Founded 2006 in London, England, United Kingdom, this venture capital invests in early stage ventures and late stage ventures. Its portfolio companies include Changing Health, Evolve Biosystems, Nutriati, Evolve Biosystems, Lumora, Allylix, and Aquapharm Biodiscovery. As of February 2020, Tate & Lyle Ventures has made 14 investments. Their most recent investment was on December 18, 2018, when Changing Health raised £3M. Tate & Lyle Ventures has had two exits, the most notable of which include Allylix and Lumora.

Edits on 18 Feb, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 18 Feb, 2020
Edits made to:
Infobox (+7/--1 properties)
Timeline (+1 events) (+7 characters)
People (+3 rows) (+6 cells) (+91 characters)
Companies (+6 rows) (+6 cells) (+75 characters)
People

Name
Role
LinkedIn

Heather Roxborough

Principal

David Atkinson

Managing Partner

Simon Barnes

Managing Partner

Companies

Company
CEO
Location
Products/Services

Allylix

Aquapharm Biodiscovery

Changing Health

Evolve Biosystems

Lumora

Nutriati

Infobox
Company status
Active
Founded date
2006
Invested in
Allylix
Timeline

2006

Founded
Edits on 10 Oct, 2019
Melanie Manipula
Melanie Manipula edited on 10 Oct, 2019
Edits made to:
Description (+115 characters)
Topic thumbnail

Tate & Lyle Ventures

Tate & Lyle Ventures is a venture capital fund investing in companies in the fields of food science and technology.

Melanie Manipula"Approved suggestion from source: https://www.twitter.com/tateandlyleplc"
Melanie Manipula approved a suggestion from Golden's AI on 10 Oct, 2019
Edits made to:
Topic thumbnail

Tate & Lyle Ventures

A venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors

Edits on 2 Oct, 2019
Reys Phillips
Reys Phillips edited on 2 Oct, 2019
Edits made to:
Infobox (+6/-1 properties)
Infobox
Location
London
Legal name
Tate & Lyle PLC
Edits on 11 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 11 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Edits made to:
Infobox (+3 properties)
Infobox
Is a
Venture capital firm
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:
Topic thumbnail

 Tate & Lyle Ventures

A venture capital firm in London that focuses on innovation and product development in healthcare and biotechnology sectors

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.